RI-MUHC research leaders talk about their respective fields of interest
Funded in part by the Canada Foundation for Innovation (CFI), the new facilities of the Research Institute of the McGill University Health Centre (RI-MUHC) at the Glen site, in Montreal, will help to bridge the gaps between biomedical research, clinical medicine and population health.
In this series of podcasts presented by the CFI, four RI-MUHC research leaders talk about their respective fields of interest and the thrill of working in the research arm of an institution that is at the forefront of health care.
Find more stories of research in action on Innovation.ca, the website of the Canada Foundation for Innovation, where these podcasts originally appeared.Read more
From left to right: Mark Ware, Igor Grant, Roger Pertwee
|The symposium Cannabis and Medicine: A New Frontier in Therapeutics, co-organized by Dr. Mark Ware, McGill University Health Centre (MUHC) pain specialist at the Montreal General Hospital (MGH) and RI member, was held at the 2015 American Association for the Advancement of Science Annual (AAAS) Meeting in San Jose (CA) last month.|
With 200 people in attendance and a series of questions from the audience that clearly demonstrated the interest in the topic and the science behind it, the event was considered a major success. In addition, the topic received extensive media coverage from journalists worldwide.
Dr. Ware was part of a panel of three international experts who gathered to discuss what scientists and doctors know or should know about cannabis and what they still have to learn.
Neuropharmacologist, Professor Roger Pertwee from the University of Aberdeen in the United Kingdom, gave the audience an overview of the science behind the plant. According to Pertwee, who has been one of the world's leading cannabinoid scientists for over 30 years, even if scientists have discovered around 100 cannabinoids, the pharmacology of most of them has yet to be investigated.
However, Dr. Igor Grant, an internationally recognized neuropsychiatrist at the University of California in San Diego, highlighted the difficulty in getting funding for clinical trials on the medical use of cannabis in the United States. According to Grant, so far meta analyses of extensive neurocognitive studies have failed to demonstrate meaningful cognitive declines among recreational users.
Dr. Ware reinforces the idea that our understanding of the role of cannabinoids in health and disease needs to be advanced through research and education for patients, physicians and policy-makers. As a pain specialist, he regularly sees patients with severe chronic pain at the Alan Edwards Pain Management Unit of the MUHC and for some of them, marijuana appears to be a credible option. According to Dr. Ware, it is time to enhance our scientific knowledge base and have informed discussions with patients.
The AAAS Annual Meeting brings together thousands of scientists, engineers, policymakers, educators, and journalists to discuss the most recent developments in science and technology.
Link to the press release: http://muhc.ca/newsroom/news/cannabis-world-renowned-researchers-discuss-new-frontier-therapeutics
Dr. Mark Ware giving his impressions after his presentation at the AAAS Annual Meeting:
|Please contact Julie Robert, MUHC Communications Coordinator, at email@example.com if you are interested in submitting a proposal for the 2016 AAAS Annual Meeting from February 11 to 15 in Washington, DC (US).|
We have always looked upon our teams as nothing less than exceptional. We know it because we see it day in and day out. To work at the Research Institute of the McGill University Health Centre (RI-MUHC) is to join a family that is bonded across labs, professions, cultures, ages and eras with the same goal and purpose: to provide the best care from bench to bedside.
We think this is what makes our Research Institute special. Thank you everyone for helping the RI-MUHC once again be top employers in Montreal! This is indeed "something to celebrate!"
Sonia Rea, Director, Human Resources and Environmental Health & Safety Division, RI-MUHC
Mediacorp organizes this prestigious national competition to evaluate the best employers in Canada based on many different criteria. This is the ninth year the MUHC and the third year the RI-MUHC have been selected.
Reminder to all Graduate Students, Post-Doctoral Fellows and their Supervisors
The deadline to submit your application for the 2015-16 RI-MUHC Studentship and Fellowship Competition is on Thursday, March 26, 2015 at noon.
Please visit the RI Portal to access the competition application and guidelines (a user name and password are required; however these can be requested at the login page).
This is a reminder that in order to submit your on-line application, all documents must be uploaded to the RI Portal (supervisor documents, referee letter of recommendation and other requested documents).
If you have any questions please contact the RI-MUHC Studentship & Fellowship Competition Administration at: firstname.lastname@example.org
MUHC Social media: Follow us now!
Follow us on:
Do you have an upcoming paper or a research project that could be of interest to the media with potential clinical implications?
If yes, let us know! If we decide to go ahead and develop a press release or a pitch you will be asked to be available for interviews with TV, radio or print media.
Before you are published, please contact Julie Robert, MUHC Communications Coordinator, at email@example.com or 514 934 1934 ext. 71381
$41 million to unlock the mysteries of aging
New hope in the fight against pain
Cannabis: World-renowned researchers discuss a new frontier in therapeutics
Revolutionary new probe zooms in on cancer cells
Smoking thins vital part of brain
The MUHC partners with the Rossy Cancer Network to smooth the rocky road of cancer survivorship
World-class research facilities: "From bench to bedside"
Blame it on your brain: salt and hypertension
Genetic discovery about childhood blindness paves the way for new treatments